Cargando…
Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy
BACKGROUND: Minimal change disease (MCD) has a high recurrence rate, but currently, no biomarker can predict its recurrence. To this end, this study aimed at identifying potential serum cytokines as valuable biomarkers for predicting the risk of MCD recurrence. MATERIALS AND METHODS: Raybiotech 440...
Autores principales: | Bai, Mengqiu, Zhang, Jian, Su, Xinwan, Yao, Xi, Li, Heng, Cheng, Jun, Mao, Jianhua, Li, Xiayu, Chen, Jianghua, Lin, Weiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729255/ https://www.ncbi.nlm.nih.gov/pubmed/36507530 http://dx.doi.org/10.3389/fmed.2022.922193 |
Ejemplares similares
-
Serum IgE Levels Are Associated With the Prognosis of Minimal Change Disease
por: Li, Heng, et al.
Publicado: (2022) -
Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
por: Yu, Guizhen, et al.
Publicado: (2021) -
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity
por: Bonnans, Caroline, et al.
Publicado: (2020) -
DNA demethylase Tet2 suppresses cisplatin-induced acute kidney injury
por: Bao, Yinwu, et al.
Publicado: (2021) -
Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)